bioAffinity Technologies (BIAF) Competitors

$2.02 -0.16 (-7.34%)

Closing price 04:00 PM Eastern

Extended Trading

$2.04 +0.02 (+0.74%)

As of 05:49 PM Eastern

BIAF vs. PHUN, ACFN, SJ, LUNA, and ARAI

Should you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include Phunware (PHUN), Acorn Energy (ACFN), Scienjoy (SJ), Luna Innovations (LUNA), and Arrive AI (ARAI). These companies are all part of the "business services" industry.

How does bioAffinity Technologies compare to Phunware?

Phunware (NASDAQ:PHUN) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

: Phunware currently has a consensus target price of $7.25, suggesting a potential upside of 248.56%. Given Phunware's stronger consensus rating and higher probable upside, equities analysts clearly believe Phunware is more favorable than bioAffinity Technologies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phunware
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
bioAffinity Technologies
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: bioAffinity Technologies has a net margin of -241.93% compared to Phunware's net margin of -446.57%. Phunware's return on equity of -10.23% beat bioAffinity Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Phunware -446.57% -10.23% -9.14%
bioAffinity Technologies -241.93% -301.67% -142.38%
: Phunware has higher earnings, but lower revenue than bioAffinity Technologies. Phunware is trading at a lower price-to-earnings ratio than bioAffinity Technologies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Phunware $2.55M 16.45 -$11.40M -$0.57 N/A
bioAffinity Technologies $6.16M 1.48 -$14.91M -$15.76 N/A
: In the previous week, bioAffinity Technologies had 1 more articles in the media than Phunware. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for Phunware. bioAffinity Technologies' average media sentiment score of 0.89 beat Phunware's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.
Company Overall Sentiment
Phunware Neutral
bioAffinity Technologies Positive
: Phunware has a beta of 2.66, indicating that its share price is 166% more volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of -1.19, indicating that its share price is 219% less volatile than the S&P 500.
: 7.6% of Phunware shares are owned by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are owned by institutional investors. 0.2% of Phunware shares are owned by insiders. Comparatively, 2.7% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phunware	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Phunware	-446.57%	-10.23%	-9.14%
bioAffinity Technologies	-241.93%	-301.67%	-142.38%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phunware	$2.55M	16.45	-$11.40M	-$0.57	N/A
bioAffinity Technologies	$6.16M	1.48	-$14.91M	-$15.76	N/A

Company	Overall Sentiment
Phunware	Neutral
bioAffinity Technologies	Positive

Summary

Phunware beats bioAffinity Technologies on 10 of the 16 factors compared between the two stocks.

How does bioAffinity Technologies compare to Acorn Energy?

Acorn Energy (NASDAQ:ACFN) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

: In the previous week, Acorn Energy had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 2 mentions for Acorn Energy and 1 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 0.89 beat Acorn Energy's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Acorn Energy
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
bioAffinity Technologies
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: 1.6% of bioAffinity Technologies shares are owned by institutional investors. 35.1% of Acorn Energy shares are owned by insiders. Comparatively, 2.7% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
: Acorn Energy has a net margin of 21.87% compared to bioAffinity Technologies' net margin of -241.93%. Acorn Energy's return on equity of 25.09% beat bioAffinity Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Acorn Energy 21.87% 25.09% 14.51%
bioAffinity Technologies -241.93% -301.67% -142.38%
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acorn Energy
0 Sell rating(s)
1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
bioAffinity Technologies
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Acorn Energy has higher revenue and earnings than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Acorn Energy, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Acorn Energy $11.48M 4.20 $2.51M $0.99 19.44
bioAffinity Technologies $6.16M 1.48 -$14.91M -$15.76 N/A
: Acorn Energy has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of -1.19, indicating that its share price is 219% less volatile than the S&P 500.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acorn Energy	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
bioAffinity Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Acorn Energy	21.87%	25.09%	14.51%
bioAffinity Technologies	-241.93%	-301.67%	-142.38%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acorn Energy	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acorn Energy	$11.48M	4.20	$2.51M	$0.99	19.44
bioAffinity Technologies	$6.16M	1.48	-$14.91M	-$15.76	N/A

Summary

Acorn Energy beats bioAffinity Technologies on 12 of the 14 factors compared between the two stocks.

How does bioAffinity Technologies compare to Scienjoy?

Scienjoy (NASDAQ:SJ) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scienjoy
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
bioAffinity Technologies
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: In the previous week, Scienjoy and Scienjoy both had 1 articles in the media. bioAffinity Technologies' average media sentiment score of 0.89 beat Scienjoy's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Scienjoy
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
bioAffinity Technologies
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: 0.3% of Scienjoy shares are owned by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are owned by institutional investors. 33.5% of Scienjoy shares are owned by insiders. Comparatively, 2.7% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: Scienjoy has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of -1.19, suggesting that its stock price is 219% less volatile than the S&P 500.
: Scienjoy has a net margin of -47.40% compared to bioAffinity Technologies' net margin of -241.93%. Scienjoy's return on equity of -57.42% beat bioAffinity Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Scienjoy -47.40% -57.42% -48.64%
bioAffinity Technologies -241.93% -301.67% -142.38%
: bioAffinity Technologies has lower revenue, but higher earnings than Scienjoy. Scienjoy is trading at a lower price-to-earnings ratio than bioAffinity Technologies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Scienjoy $1.33B 0.03 -$83.95M -$2.01 N/A
bioAffinity Technologies $6.16M 1.48 -$14.91M -$15.76 N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scienjoy	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Scienjoy	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
bioAffinity Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Scienjoy	-47.40%	-57.42%	-48.64%
bioAffinity Technologies	-241.93%	-301.67%	-142.38%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scienjoy	$1.33B	0.03	-$83.95M	-$2.01	N/A
bioAffinity Technologies	$6.16M	1.48	-$14.91M	-$15.76	N/A

Summary

Scienjoy beats bioAffinity Technologies on 7 of the 12 factors compared between the two stocks.

How does bioAffinity Technologies compare to Luna Innovations?

bioAffinity Technologies (NASDAQ:BIAF) and Luna Innovations (NASDAQ:LUNA) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
bioAffinity Technologies
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Luna Innovations
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: In the previous week, bioAffinity Technologies and bioAffinity Technologies both had 1 articles in the media. bioAffinity Technologies' average media sentiment score of 0.89 beat Luna Innovations' score of 0.75 indicating that bioAffinity Technologies is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
bioAffinity Technologies
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Luna Innovations
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: 1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 87.5% of Luna Innovations shares are owned by institutional investors. 2.7% of bioAffinity Technologies shares are owned by company insiders. Comparatively, 7.6% of Luna Innovations shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
: bioAffinity Technologies has a beta of -1.19, suggesting that its share price is 219% less volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 1.87, suggesting that its share price is 87% more volatile than the S&P 500.
: Luna Innovations has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -241.93%. Luna Innovations' return on equity of 0.00% beat bioAffinity Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
bioAffinity Technologies -241.93% -301.67% -142.38%
Luna Innovations N/A N/A N/A
: Luna Innovations has higher revenue and earnings than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Luna Innovations, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
bioAffinity Technologies $6.16M 1.48 -$14.91M -$15.76 N/A
Luna Innovations $116.61M 0.29 $9.28M $0.03 33.67

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Luna Innovations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
bioAffinity Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Luna Innovations	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	-241.93%	-301.67%	-142.38%
Luna Innovations	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$6.16M	1.48	-$14.91M	-$15.76	N/A
Luna Innovations	$116.61M	0.29	$9.28M	$0.03	33.67

Summary

Luna Innovations beats bioAffinity Technologies on 10 of the 13 factors compared between the two stocks.

How does bioAffinity Technologies compare to Arrive AI?

bioAffinity Technologies (NASDAQ:BIAF) and Arrive AI (NASDAQ:ARAI) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

: Arrive AI has a consensus target price of $12.00, suggesting a potential upside of 1,639.13%. Given Arrive AI's stronger consensus rating and higher possible upside, analysts clearly believe Arrive AI is more favorable than bioAffinity Technologies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
bioAffinity Technologies
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Arrive AI
1 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: In the previous week, bioAffinity Technologies and bioAffinity Technologies both had 1 articles in the media. bioAffinity Technologies' average media sentiment score of 0.89 beat Arrive AI's score of 0.10 indicating that bioAffinity Technologies is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
bioAffinity Technologies
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Arrive AI
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 1.6% of bioAffinity Technologies shares are owned by institutional investors. 2.7% of bioAffinity Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
: Arrive AI has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -241.93%. Arrive AI's return on equity of -176.63% beat bioAffinity Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
bioAffinity Technologies -241.93% -301.67% -142.38%
Arrive AI N/A -176.63% -83.87%
: Arrive AI has lower revenue, but higher earnings than bioAffinity Technologies. Arrive AI is trading at a lower price-to-earnings ratio than bioAffinity Technologies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
bioAffinity Technologies $6.16M 1.48 -$14.91M -$15.76 N/A
Arrive AI $110K 299.40 -$12.83M -$0.41 N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Arrive AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
bioAffinity Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Arrive AI	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	-241.93%	-301.67%	-142.38%
Arrive AI	N/A	-176.63%	-83.87%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$6.16M	1.48	-$14.91M	-$15.76	N/A
Arrive AI	$110K	299.40	-$12.83M	-$0.41	N/A

Summary

Arrive AI beats bioAffinity Technologies on 9 of the 14 factors compared between the two stocks.

Get bioAffinity Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIAF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BIAF vs. The Competition

Export

Metric	bioAffinity Technologies	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$9.09M	$3.39B	$6.25B	$11.87B
Dividend Yield	N/A	2.20%	2.73%	5.21%
P/E Ratio	-0.13	38.85	29.04	28.47
Price / Sales	1.48	155.51	476.61	60.92
Price / Cash	N/A	57.88	27.62	36.52
Price / Book	1.25	7.03	9.67	6.67
Net Income	-$14.91M	$23.62M	$3.55B	$332.53M
7 Day Performance	-24.06%	3.68%	1.70%	2.01%
1 Month Performance	-48.47%	7.16%	5.62%	9.19%
1 Year Performance	-82.28%	67.05%	34.41%	39.59%

bioAffinity Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BIAF bioAffinity Technologies	0.3663 of 5 stars	$2.02 -7.3%	N/A	N/A	$9.09M	$6.16M	N/A	10	Positive News
PHUN Phunware	1.6808 of 5 stars	$2.24 -0.4%	$7.25 +223.7%	N/A	$45.23M	$2.55M	N/A	120	Positive News Upcoming Earnings
ACFN Acorn Energy	0.7696 of 5 stars	$17.65 -2.0%	N/A	N/A	$44.30M	$11.48M	17.83	20	News Coverage Positive News Upcoming Earnings
SJ Scienjoy	0.6957 of 5 stars	$1.10 flat	N/A	N/A	$43.49M	$177.55M	N/A	280	News Coverage
LUNA Luna Innovations	N/A	$1.05 -4.5%	N/A	N/A	$35.66M	$116.61M	35.00	390	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BIAF) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

bioAffinity Technologies (BIAF) Competitors

BIAF vs. PHUN, ACFN, SJ, LUNA, and ARAI

How does bioAffinity Technologies compare to Phunware?

Summary

How does bioAffinity Technologies compare to Acorn Energy?

Summary

How does bioAffinity Technologies compare to Scienjoy?

Summary

How does bioAffinity Technologies compare to Luna Innovations?

Summary

How does bioAffinity Technologies compare to Arrive AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIAF vs. The Competition

bioAffinity Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

bioAffinity Technologies (BIAF) Competitors

BIAF vs. PHUN, ACFN, SJ, LUNA, and ARAI

How does bioAffinity Technologies compare to Phunware?

Summary

How does bioAffinity Technologies compare to Acorn Energy?

Summary

How does bioAffinity Technologies compare to Scienjoy?

Summary

How does bioAffinity Technologies compare to Luna Innovations?

Summary

How does bioAffinity Technologies compare to Arrive AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIAF vs. The Competition

bioAffinity Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools